RGLS REGULUS THERAPEUTICS INC Expansion Plans 8-K Filing 2024 - License Agreement Regulus Therapeutics Inc. has entered into a licensing agreement with The University of Texas at Southwestern Medical Center for patent rights related to treatments for kidney disease, paying an upfront fee of $62,500 and potential milestone payments totaling up to $4.1 million.Get access to all SEC 8-K filings of the REGULUS THERAPEUTICS INC